603590.SH
康辰药业
SSE · Healthcare · Biotechnology · CN
CNY 30.12
−6.49%Margins
Gross margin
89.8%
EBITDA margin
25.8%
EBIT margin
22.5%
Net margin
18.4%
FCF margin
13.9%
5.2%
Return on equity
4.1%
Return on assets
5.8%
Return on invested capital
0.22x
Asset turnover
CNY 167.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026